Iterum Therapeutics Plc (ITRM) Tops Q3 EPS by 47c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.43), $0.47 better than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
• Goldman Sachs Downgrades Bank Mandiri (BMRI:IJ) (PPERF) to Sell, 'Liquidity and capital tightness'